[1]
|
Sharma NS. Patient centric approach for clinical trials: Current trend and new opportunities[J]. Perspect Clin Res, 2015, 6: 134-138. doi: 10.4103/2229-3485.159936 |
[2]
|
Smith MY, Benattia I. The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization[J]. Drug Saf, 2016, 39: 779-785. doi: 10.1007/s40264-016-0426-9 |
[3]
|
Dockendorf MF, Hansen BJ, Bateman KP, et al. Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm[J]. Clin Transl Sci, 2021, 14: 445-459. doi: 10.1111/cts.12910 |
[4]
|
Babiker HM, Davis L, Larson K, et al. A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations[J]. Expert Opin Investig Drugs, 2019, 28: 675-686. doi: 10.1080/13543784.2019.1646726 |
[5]
|
Patalano F, Gutzwiller FS, Shah B, et al. Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: Patient-Centric Drug Development from Theory to Practice[J]. Adv Ther, 2020, 37: 17-26. doi: 10.1007/s12325-019-01134-x |
[6]
|
Desai A, Warner J, Kuderer N, et al. Crowdsourcing a crisis response for COVID-19 in oncology[J]. Nat Cancer, 2020: 1-4. doi: 10.1038/s43018-020-0065-z.[Epubahead of print]. |
[7]
|
Day S, Mathews A, Blumberg M, et al. Broadening community engagement in clinical research: Designing and assessing a pilot crowdsourcing project to obtain community feedback on an HIV clinical trial[J]. Clin Trials, 2020, 17: 306-313. doi: 10.1177/1740774520902741 |
[8]
|
Leiter A, Sablinski T, Diefenbach M, et al. Use of Crowdsourcing for Cancer Clinical Trial Development[J]. J Natl Cancer Inst, 2014, 106: dju258. http://www.onacademic.com/detail/journal_1000036697570210_e183.html |
[9]
|
Lee YJ, Arida JA, Donovan HS. The application of crowdsourcing approaches to cancer research: a systematic review[J]. Cancer Med, 2017, 6: 2595-2605. doi: 10.1002/cam4.1165 |
[10]
|
P Bateman K. The development of patient-centric sampling as an enabling technology for clinical trials[J]. Bioanalysis, 2020, 12: 971-976. doi: 10.4155/bio-2020-0075 |
[11]
|
James CA, Barfield MD, Maass KF, et al. Will patient-centric sampling become the norm for clinical trials after COVID-19?[J]. Nat Med, 2020, 26: 1810. doi: 10.1038/s41591-020-01144-1 |
[12]
|
Lamberti MJ, Awatin J. Mapping the Landscape of Patient-centric Activities Within Clinical Research[J]. Clin Ther, 2017, 39: 2196-2202. doi: 10.1016/j.clinthera.2017.09.010 |
[13]
|
U.S. Department of Health and Human Services Food and Drug Administration. Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Draft Guidance for Industry and Food and Drug Administration Staff, And Other Stakeholders[EB/OL]. [2021-1-11]. https://www.fda.gov/media/139088/download. |
[14]
|
Annapureddy N, Devilliers H, Jolly M. Patient-reported outcomes in lupus clinical trials with biologics[J]. Lupus, 2016, 25: 1111-1121. doi: 10.1177/0961203316652494 |
[15]
|
冯仁田, 杨志清. 欧美临床试验文件中通俗化语言的应用[J]. 中国新药与临床杂志, 2021, 40: 356-361. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL202105007.htm
Feng RT, Yang ZQ. Application of plain language in clinical study documents in European and American[J]. Zhongguo Xinyao Yu Linchuang Zazhi, 2021, 40: 356-361. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL202105007.htm |
[16]
|
Richards DP, Birnie KA, Eubanks K, et al. Guidance on authorship with and acknowledgement of patient partners in patient-oriented research[J]. Res Involv Engagem, 2020, 6: 38. doi: 10.1186/s40900-020-00213-6 |
[17]
|
Arnstein L, Wadsworth AC, Yamamoto BA, et al. Patient involvement in preparing health research peer-reviewed publications or results summaries: a systematic review and evidence-based recommendations[J]. Res Involv Engagem, 2020, 6: 34. doi: 10.1186/s40900-020-00190-w |
[18]
|
Li CC, Dockendorf M, Kowalski K, et al. Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling[J]. J Clin Pharmacol, 2018, 58: 294-303. doi: 10.1002/jcph.1021 |
[19]
|
Faulkner M, Alikhaani J, Brown L, et al. Exploring Meaningful Patient Engagement in ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness)[J]. Med Care, 2018, 56: S11-S15. doi: 10.1097/MLR.0000000000000949 |
[20]
|
Marquis-Gravel G, Robertson H, Jones WS, et al. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial[J]. Trials, 2021, 22: 90. doi: 10.1186/s13063-021-05026-w |